1. Home
  2. DRVN vs NNNN Comparison

DRVN vs NNNN Comparison

Compare DRVN & NNNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Driven Brands Holdings Inc.

DRVN

Driven Brands Holdings Inc.

HOLD

Current Price

$12.54

Market Cap

1.7B

ML Signal

HOLD

Logo Anbio Biotechnology Class A Ordinary Shares

NNNN

Anbio Biotechnology Class A Ordinary Shares

HOLD

Current Price

$27.96

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DRVN
NNNN
Founded
1972
2021
Country
United States
Germany
Employees
N/A
N/A
Industry
Automotive Aftermarket
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.5B
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
DRVN
NNNN
Price
$12.54
$27.96
Analyst Decision
Buy
Analyst Count
8
0
Target Price
$19.57
N/A
AVG Volume (30 Days)
2.0M
17.9K
Earning Date
05-05-2026
04-28-2026
Dividend Yield
N/A
N/A
EPS Growth
59.82
N/A
EPS
0.69
N/A
Revenue
$2,339,588,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$1.53
N/A
P/E Ratio
$18.15
$446.57
Revenue Growth
1.54
N/A
52 Week Low
$9.80
$5.99
52 Week High
$19.74
$55.65

Technical Indicators

Market Signals
Indicator
DRVN
NNNN
Relative Strength Index (RSI) 53.00 61.11
Support Level $9.92 $26.48
Resistance Level $15.91 $30.70
Average True Range (ATR) 0.62 2.12
MACD 0.22 0.59
Stochastic Oscillator 69.57 87.64

Price Performance

Historical Comparison
DRVN
NNNN

About DRVN Driven Brands Holdings Inc.

Driven Brands Holdings Inc is an automotive services company in North America. Its platform provides high-quality services to an extensive range of retail and commercial customers. The company provides an extensive range of core consumer and commercial automotive needs, including paint, collision, glass, and repair services, as well as a variety of high-frequency services, such as oil changes and car washes. The company segments include: Maintenance, Car Wash, Paint, Collision & Glass, and Platform Services. It derives maximum revenue from Maintenance Segment. Geographically, the company operates into United States, Canada and Rest of the World.

About NNNN Anbio Biotechnology Class A Ordinary Shares

Anbio Biotechnology is a medical device company focused on in vitro diagnostics. It offers laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions to detect a wide range of biomarkers associated with critical medical domains encompassing infectious diseases, cancer, cardiovascular diseases, inflammation, drug abuse, endocrine disorders, renal disease, pharmacogenomics, and diabetes. Its product portfolio comprises AF-1200 Fluorescence Immunoassay Analyzer, SHA-100 Dry Chemistry Analyzer, Ferritin Rapid Test Kit, Dengue NS1 Rapid Test, Multi-HBV Rapid Test, COVID-19 Test Kit (Real-time PCR), and others. Geographically, the company generates maximum revenue from the European Union, followed by South America, Asia Pacific, North America, and other regions.

Share on Social Networks: